Characterization of the Anti-Diabetic and Antioxidant Effects of Rehmannia Glutinosa in Streptozotocin-Induced Diabetic Wistar Rats

American Journal of Chinese Medicine

Volumn 36, Issue 6, 2008, Pages 1083-1104

  Waisundara, Viduranga Y ^a   Huang, Meiqi ^a   Hsu, Annie ^b   Huang, Dejian ^a   Tan, Benny Kwong Huat ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

C Reactive Protein; Diabetes; Metformin; Traditional Chinese Medicine

Indexed keywords

6' O ALPHA LEVO ARABINOPYRANOSYLMARTYNOSIDE; ACTEOSIDE; ALCOHOL; C REACTIVE PROTEIN; CATALPOL; GLUCOSE; ISOACTEOSIDE; MARTYNOSIDE; METFORMIN; ORAL ANTIDIABETIC AGENT; PLANT MEDICINAL PRODUCT; REHMANNIA GLUTINOSA EXTRACT; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DETERMINATION; DRUG STRUCTURE; FRACTIONATION; GLUCOSE BLOOD LEVEL; HERB; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; REHMANNIA; STREPTOZOCIN DIABETES; STRUCTURE ANALYSIS; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; C-REACTIVE PROTEIN; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; HYPOGLYCEMIC AGENTS; MALE; RATS; RATS, WISTAR; REHMANNIA; STREPTOZOCIN;

EID: 57349135217     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X08006594     Document Type: Article

References (37)

1. Bojestig, M., H.J. Arnqvist, G. Hermansson, B.E. Karlberg and J. Ludvigsson. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. New Engl. J. Med. 330: 15-18, 1994.
2. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
3. Brownlee, M. The pathobiology of diabetes: A unified mechanism (Banting lecture). Diabetes 54: 1615-1625, 2005.
4. Cnop, M., N. Welsh, J. Jean-Christope, A. Jorns, S. Senzen and D. Eizirk. Mechanisms of β-cell death in type I and type II diabetes. Diabetes 54(Suppl. 2): S97-S107, 2005.
5. Chiou, W.F., L.C. Lin and C.F. Chen. Acteoside protects endothelial cells against free radical-induced oxidative stress. J. Pharm. Pharmacol. 56: 743-746, 2004.
6. Davies, K.J.A. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 50: 279-289, 2000.
7. Evans, J.L., B.A. Maddux and I.D. Goldfine. Antioxidants in diabetic complications and insulin resistance. In: I. Raz et al. (eds.) Diabetes: From Research to Diagnosis and Treatment. Martin Dunitz, London, 2003, pp. 479-496.
8. Finkel, T. Oxidants, oxidative stress and the biology of aging. Nature 408: 239-248, 2000.
9. Hay, K.X., V.Y. Waisundara, Z. Yong, M.Y. Han and D.J. Huang. CdSe Nanocrystals as hydroperoxide scavengers: A new approach to highly sensitive quantification of lipid hydroperoxides. Small 3: 290-293, 2007.
10. Hovind, P., L. Tarnow, K. Rossing, P. Rossing, S. Eising, N. Larsen, C. Binder and H.H. Parving. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26: 1258-1264, 2003.
11. Huang, D.J., B.X. Ou, M. Hampsch-Woodill, J.A. Flanagan and R.L. Prior. High-throughput assay of Oxygen Radical Absorbance Capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format. J. Agric. Food Chem. 50: 4437-4444, 2002.
12. Jiang, B., J.H. Liu, Y.M. Bao and L.J. An. Catalpol inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade. Toxicon 43: 53-59, 2004
13. Ko, K.M., D.H.F. Mak, P.Y. Chiu and M.K.T. Poon. Pharmacological basis of yang-invigoration in Chinese medicine. Trends Pharmacol. Sci. 25: 3-6, 2005.
14. Kuehn, B. "Polypill" could slash diabetes risks. J. Am. Med. Assoc. 296: 378-380, 2006.
15. Li, J., R.L. Zheng, Z.M. Liu and Z.J. Jia. Scavenging effects of phenylpropenoid glycosides on superoxide and its antioxidation effect. Acta Pharmacol. Sin. 13: 427-430, 1992.
16. Lonn, E., S. Yusuf, B. Hoogwerf, J. Pogue, Q. Yi, B. Zinman, J. Bosch, G. Dagenais, J.F. Mann, H.C. Gerstein, H. Study and M.H. Study. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: Results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 25: 1919-1927, 2002.
17. Li, W.L., H.C. Zheng, J. Bukuru and N. De Kimpe. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus (review). J. Ethnopharmacol. 92: 1-21, 2004.
18. Ou, B.X., D.J. Huang, M. Hampsch-Woodill and J. Flanagan. When east meets west: The relationship between yin-yang and antioxidation - oxidation. FASEB J. 17: 127-129, 2003.
19. Packer, L. Oxidative stress and antioxidants: The antioxidant network, alpha-lipoic acid and diabetes. In: L. Packer et al. (eds) Antioxidants in Diabetes Management. Marcel Dekker, New York, 2000, 1-16.
20. Rhodes, C. Type II diabetes: A matter of β-cell life or death? Science 307: 380-384, 2005.
21. Scalabrini, P., M. Rossi, P. Spettoli and M. Matteuzzi. Characterization of Bifidobacterium strains for use in soymilk fermentation. Int. J. Food Microbiol. 39: 213-220, 1998.
22. Suckow, M.A., C.L. Franklin and S.H. Weisbroth. Clinical pathology of the rat. In: M.A. Suckow et al. (eds.) The Laboratory Rat. Elsevier Inc., Burlington, MA, 2006, pp. 132-133.
23. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 329: 977-986, 1993.
24. The Diabetes Control and Complications Trial Research Group (DCTT). Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46: 1829-1839, 1997.
25. The Diabetes Control and Complications Trial (DCTT)/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. New Engl. J. Med. 342: 381-389, 2000.
26. UK Prospective Diabetes Study (UKPDS) Group. Relative efficacy of sulfonylurea, insulin and met-formin therapy in newly diagnosed non-insulin dependent diabetes with primary diet failure followed for six years (UKPDS 24). Ann. Int. Med. 128: 165-175, 1998a.
27. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998b.
28. UK Prospective Diabetes Study Group (UKPDS). Association of hyperglycemia with macrovascular and microvascular complications of type 2 diabetes: A prospective observational study (UKPDS 35). Br. Med. J. 321: 405-412, 1998c.
29. Wang, H., B. Bian, J. Yang and T. Wang, Catalpol content changes in Rehmannia glutinosa (Gaertn.) Libosch. under certain conditions. Zhongguo Zhong Yao Za Zhi. 22: 408-409, 1997.
30. Wong, C.C., H.B. Li, K.W. Cheng and F. Chen. A systematic survey of antioxidant activity of 30 Chinese medicinal plants using the ferric reducing antioxidant power assay. Food Chem. 97: 705-711, 2006.
31. Wu, Y.T., L.C. Lin, J.S. Sung and T.H. Tsa. Determination of acteoside in Cistanche deserticola and Boschniakia rossica and its pharmacokinetics in freely-moving rats using LC-MS/MS. J. Chromatogr. B 884: 89-95, 2006.
32. Xiao, M., K. Tanaka, X. Qian, K. Yamamoto and H. Kumagai. High-yield production and characterization of α-galactosidase from Bifidobacterium breve grown on raffinose. Biotechnol. Lett. 22: 747-758, 2000.
33. Yin, J., G. Yang, S. Wang and Y. Chen. Purification and determination of stachyose inChinese artichoke (Stachys sieboldii Miq.) by high-performance liquid chromatography with evaporative light scattering detection. Talanta 70: 208-212, 2006.
34. Yu, H.H., S.J. Seo, Y.H. Kim, H.Y. Lee, R.K. Park, H.S. So, S.I. Jang and Y.O. You. Protective effect of Rehmannia glutinosa on the cisplatin-induced damage of HEI-OC1 auditory cells through scavenging free radicals. J. Ethnopharmacol. 107: 383-388, 2006.
35. Zhang, R., J. Zhou, Z. Jia, Y. Zhang and G. Gu. Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism. J. Ethnopharmacol. 90: 39-43, 2004a.
36. Zhang, R.X., Z.P. Jia, L.Y. Kong, H.P. Ma, J. Ren, M.X. Li and X. Ge. Stachyose extract from Rehmannia glutinosa Libosch. to lower plasma glucose in normal and diabetic rats by oral administration. Pharmazie 59: 552-556, 2004b.
37. Zhao, C., G. Dodin, C. Yuan, H. Chen, R. Zheng, Z. Jia and B. T. Fan. In vitro protection of DNA from Fenton reaction by plant polyphenol verbascoside. Biochem. Biochim. Acta 1723: 114-118, 2005.